grant

Dysregulation of cortical astrocytes in models of Alzheimer's Disease

Organization YALE UNIVERSITYLocation NEW HAVEN, UNITED STATESPosted 15 May 2025Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY2025AD dementiaAD modelAD pathologyAPP-PS1APP/PS1AccelerationAddressAffectAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimer's disease modelAlzheimer's disease pathologyAlzheimer's pathologyAlzheimers DementiaAnatomic SitesAnatomic structuresAnatomyAnimalsAreaArousalAstrocytesAstrocytusAstrogliaAttentionAxonBehavior monitoringBrainBrain Nervous SystemCalcium Ion SignalingCalcium SignalingCell Communication and SignalingCell SignalingCerebral cortexCognitionCognitive DisturbanceCognitive ImpairmentCognitive ManifestationsCognitive SymptomsCognitive declineCognitive function abnormalCouplingDataDegenerative Neurologic DisordersDiseaseDisorderDisturbance in cognitionEncephalonExhibitsFutureGenesGeneticGenetic ModelsGoalsHumanImageImpaired cognitionIndividualInflammatoryInflammatory ResponseIntracellular Communication and SignalingLevarterenolLevonorepinephrineLocus CoeruleusMeasurementMediatingMemoryMetabolic PathwayMiceMice MammalsModelingModern ManMonitorMurineMusNeocortexNerve CellsNerve Impulse TransmissionNerve TransmissionNerve UnitNervous System Degenerative DiseasesNeural CellNeural Degenerative DiseasesNeural degenerative DisordersNeurobehavioral ManifestationsNeurobehavioral Signs and SymptomsNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNeuronal TransmissionNeuronsNoradrenalineNorepinephrineNucleus Pigmentosus PontisParalysis AgitansParkinsonParkinson DiseasePathologyPlayPrimary ParkinsonismPrimary Senile Degenerative DementiaProcessRegulationReporterResolutionRoleSignal TransductionSignal Transduction SystemsSignalingStructureSynapsesSynapticSystemTechniquesTestingTherapeuticTimeWorkadvanced diseaseadvanced illnessalzheimer modelastrocytic gliaawakeaxon signalingaxon-glial signalingaxonal signalingbehavioral monitoringbiological signal transductionblue nucleuscell typecognitive dysfunctioncognitive losscognitive processcompare to controlcomparison controldegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdisease modeldisorder modelexperimentexperimental researchexperimental studyexperimentsglia signalingglial signalinghomotypical cortexhuman modelimagingimaging approachimaging based approachin vivoinsightisocortexlife spanlifespanlocus ceruleus structuremodel of humanmouse modelmurine modelmutantneocorticalneopalliumnerve cell deathnerve cell lossnerve signalingneuralneural controlneural regulationneural signalingneurobehavioral symptomneurodegenerative illnessneuromodulationneuromodulatoryneuron cell deathneuron cell lossneuron deathneuron lossneuronalneuronal cell deathneuronal cell lossneuronal deathneuronal lossneuronal signalingneuroregulationneurotransmissionnoradrenergicnovelnovel imaging techniquepreventpreventingprimary degenerative dementiaresolutionsresponsesenile dementia of the Alzheimer typesocial rolespatial and temporalspatial temporalspatiotemporalsynapsesynapse functionsynaptic functiontherapeutic evaluationtherapeutic testing
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY:
Disruption of astrocytes, a cell type that plays key roles in inflammatory responses and synaptic function

in the brain, is a key hallmark of advanced Alzheimer's Disease (AD). Astrocytes exhibit robust state-dependent

modulation via noradrenergic signaling. Loss of neuromodulatory inputs to the cerebral cortex in AD contributes

to dysregulation of attention, arousal, and cognition, processes that are robustly modulated by release of

norepinephrine (NE). Functional dysregulation of the coupling between neuromodulatory systems and astrocytic

function likely precedes late-stage loss of neurons and contributes to early cognitive symptoms. However,

despite extensive anatomical evidence, there is little functional data on astrocytic or neuromodulatory signaling

across stages of pathology. In addition, technical limitations have precluded longitudinal measurements of

astrocytic or neuromodulatory signaling in genetic models of disease. To address this gap, we propose to

combine novel imaging approaches, including wide-field `mesoscopic' imaging of astrocytic, neural, and NE

signaling across the entire cortex in awake behaving animals. Using two genetic models of AD, we will test the

following hypotheses: (1) The initial consequence of pathology is early loss of state-dependent spatiotemporal

dynamics of astrocytic signaling. (2) AD pathology causes a progressive loss of coupling between noradrenergic

signaling and astrocyte activity. Importantly, we will longitudinally track changes over time within each animal

and also compare across models to identify convergent signatures of disease-related dysregulation. Our results

will provide an unprecedented level of insight into the disruption of key brain systems throughout the lifetime in

models of Alzheimer's Disease and provide a novel framework for future evaluation of therapeutic approaches.

Grant Number: 1R21AG087186-01A1
NIH Institute/Center: NIH

Principal Investigator: JESSICA CARDIN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →